Join us for a two-day course providing lectures and hands-on practice with novel and existing diabetes technologies. The course content ranges from cutting-edge research to the technologies used in daily clinical practice, and gives you unique insight into both worlds.
Submit your application for funding for education and networking activities in diabetes, metabolism and classical endocrinology research fields to be held during spring 2024 before the deadline on 1 October.
Are you a postdoc searching for funding? Are you looking for inspiration and motivation? Then join our DDEA Webinar Series on Grant Writing: Identifying Opportunities and Learning from Success Stories.
Save the date for the DDEA Annual Day on 31 January 2024 at Hotel Storebælt in Nyborg. More information will follow.
Visiting Professor David Beran has now finished his white book that compiles existing data on type 1 diabetes in Denmark. Together with the just published article ”Type 1 Diabetes and Health Information Systems: Lessons from Denmark” in the European Medical Journal, the hope is that the white book will be used as a roadmap to […]
How you portray people who live with a health issue is important when it comes to shaping attitudes and behaviour. Media, health professionals, organisations and others who disseminate and describe people who live with health issues through pictures and language play a central role our understanding and attitudes towards a subject such as obesity and […]
Center for Clinical Metabolic Research invites you to join their symposium on the novel LEAP2 peptide. LEAP2 has been identified as an antagonist of the hunger hormone ghrelin and is thus expected to play an important yet fairly undiscovered role in the regulation of appetite and metabolism. The symposium features presentations on regulation of LEAP2, […]
It is time to sign up for the Danish RNA Society’s 8th Annual Meeting on RNA on 10 October 2023. At the annual meeting researchers from academia and industry are coming together and getting updates on that is going on in the RNA-field internationally as well as in the Danish industry. There will be ample […]
With 53,000 employees worldwide, Boehringer Ingelheim is a leading global pharmaceutical company that aims to develop novel treatments and technologies. Boehringer Ingelheim invites talented early-career researchers to solve pre-defined scientific questions with innovative solutions for the benefit of patients. Member of the DDEA Advisory Board, Nicolas Dumoulin, is Head of Corporate Strategy & Development at […]
We are happy to welcome our Administrative Student Assistant, Svajūnė Gurklytė, to the DDEA Secretariat. In the role as Administrative Student Assistant, Svajūnė Gurklytė’s main task is to handle ad hoc administrative tasks related to the DDEA activities within education, networking, grants and communications. “The academy’s values align closely with my personal principles, particularly as […]
From understanding carnivorous plants to developing antimicrobial strategies for pen injectors, Sofia Wareham Mathiassen’s research life is characterized by high levels of curiosity and inventiveness. And in many ways, she has only just begun. Sofia Wareham Mathiassen is a biomedical engineer from the Danish Technical University (DTU) and the University of Copenhagen. This year, Sofia finished […]
Earlier this year saw the establishment of a new research centre focusing on making a difference for people with metabolic disease through RNA medicine. Professor of Medical Biology and member of the DDEA Committee for Education, Louise Torp Dalgaard, will be one of the driving forces behind the new centre. The Centre for RNA Therapeutics […]
A study found a very high seroprevalence of SARS-CoV-2 antibodies in mother-children pairs in rural north-eastern Tanzania. Line Hjort shares her insights from the study, as well as from her time doing research in Tanzania while the country’s government was downplaying the COVID-19 pandemic. During the first year of the COVID-19 pandemic, Tanzania’s then government […]
A proof-of-concept study by DDA-funded Visiting Professor Sam El-Osta’s team demonstrates that ductal cells derived from the human pancreas can be influenced by pharmacological stimulation to regenerate beta-like cells that functionally release insulin. – While pharmaceutical options receive warranted attention for the treatment of diabetes help control blood glucose levels, they do not prevent, retard […]
In June, we announced the first DDEA grant recipients. 13.6 million Danish kroner was allocated to 14 Danish and international early-career researchers and three visiting professors.
The Danish Diabetes and Endocrine Academy's mission is to foster early-career research talent through education and talent development, networking and collaboration, and grants.Allan Flyvbjerg Chairman of the Board of Directors